Claritev ROA 2019-2025 | CTEV
Current and historical return on assets (ROA) values for Claritev (CTEV) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Claritev ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-03-31 | $-1.18B | $5.09B | -22.11% |
| 2024-12-31 | $-1.65B | $5.15B | -29.16% |
| 2024-09-30 | $-1.54B | $5.32B | -25.24% |
| 2024-06-30 | $-1.17B | $5.74B | -17.94% |
| 2024-03-31 | $-0.63B | $6.37B | -9.17% |
| 2023-12-31 | $-0.09B | $6.97B | -1.28% |
| 2023-09-30 | $-0.71B | $7.06B | -9.87% |
| 2023-06-30 | $-0.67B | $7.14B | -8.91% |
| 2023-03-31 | $-0.62B | $7.22B | -7.95% |
| 2022-12-31 | $-0.57B | $7.37B | -7.14% |
| 2022-09-30 | $0.10B | $8.19B | 1.25% |
| 2022-06-30 | $0.16B | $8.22B | 1.95% |
| 2022-03-31 | $0.10B | $8.28B | 1.21% |
| 2021-12-31 | $0.10B | $8.22B | 1.23% |
| 2021-09-30 | $-0.10B | $8.28B | -1.15% |
| 2021-06-30 | $-0.46B | $8.34B | -7.08% |
| 2021-03-31 | $-0.47B | $8.36B | -9.99% |
| 2020-12-31 | $-0.52B | $8.28B | -17.92% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.725B | $0.931B |
| Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.159B | 58.73 |
| Doximity (DOCS) | United States | $11.724B | 54.28 |
| Hims & Hers Health (HIMS) | United States | $11.606B | 120.58 |
| Tempus AI (TEM) | United States | $10.382B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.374B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.760B | 58.76 |
| Hinge Health (HNGE) | United States | $3.663B | 0.00 |
| Privia Health (PRVA) | United States | $2.509B | 171.50 |
| Enovis (ENOV) | United States | $1.745B | 9.73 |
| Phreesia (PHR) | United States | $1.609B | 0.00 |
| Schrodinger (SDGR) | United States | $1.559B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.537B | 0.00 |
| 10x Genomics (TXG) | United States | $1.523B | 0.00 |
| Azenta (AZTA) | United States | $1.469B | 68.25 |
| Evolent Health (EVH) | United States | $1.343B | 114.40 |
| Omnicell (OMCL) | United States | $1.301B | 22.96 |
| Fulgent Genetics (FLGT) | United States | $0.549B | 0.00 |
| Veradigm (MDRX) | United States | $0.499B | 0.00 |
| Standard BioTools (LAB) | United States | $0.471B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.443B | 0.00 |
| Talkspace (TALK) | United States | $0.416B | 124.25 |
| TruBridge (TBRG) | United States | $0.326B | 722.33 |
| Outset Medical (OM) | United States | $0.321B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.271B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.264B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.241B | 0.00 |
| CapsoVision (CV) | United States | $0.221B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.188B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.144B | 0.00 |
| American Well (AMWL) | United States | $0.129B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.121B | 0.00 |
| Pulmonx (LUNG) | United States | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.104B | 0.00 |
| CareCloud (CCLD) | United States | $0.102B | 3.87 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.088B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.081B | 0.00 |
| 111 (YI) | China | $0.065B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.047B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |